Profile data is unavailable for this security.
About the company
Zhejiang Shouxiangu Pharmaceutical Co Ltd is a China-based company principally engaged in the breeding, cultivation, processing and sales of traditional Chinese medicinal materials, such as the ganoderma lucidums and dendrobium officinales. The Company's main products include ganoderma lucidum spore powder, Tiepi Fengdou granule, ganoderma extract products and fresh dendrobium officinales, among others. The Company mainly operates its businesses in domestic markets through wholesaling and direct sales.
- Revenue in CNY (TTM)713.75m
- Net income in CNY233.79m
- Incorporated1997
- Employees1.14k
- LocationZhejiang Shouxiangu Pharmaceutical Co LtdNo. 12 Huanglong 3rd Road, Wuyi CountyJINHUA 321200ChinaCHN
- Phone+86 57 987622285
- Fax+86 57 987621769
- Websitehttp://www.sxg1909.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang Shouxiangu Pharmaceuticl Co Ltd | 713.75m | 233.79m | 4.29bn | 1.14k | 18.15 | 1.92 | -- | 6.01 | 1.19 | 1.19 | 3.63 | 11.26 | 0.2367 | 0.7194 | 7.25 | 624,455.80 | 7.75 | 10.04 | 9.09 | 11.63 | 80.01 | 83.66 | 32.75 | 28.29 | 3.48 | -- | 0.2098 | 47.86 | -5.39 | 8.93 | -8.39 | 18.78 | 12.23 | 17.13 |
| Lionco Pharmaceutical Group Co Ltd | 277.20m | -101.80m | 4.31bn | 475.00 | -- | 5.03 | -- | 15.53 | -0.144 | -0.144 | 0.3828 | 1.19 | 0.1843 | 2.48 | 4.41 | 583,571.30 | -6.77 | 0.7396 | -7.85 | 0.9562 | 41.77 | 80.88 | -36.73 | 2.08 | 4.94 | -4.74 | 0.2409 | 521.93 | -31.95 | -34.79 | 22.65 | -- | -33.18 | -- |
| Chengdu Olymvax Biopharmaceuticals Inc | 530.47m | -8.70m | 4.32bn | 471.00 | -- | 4.74 | -- | 8.13 | -0.0219 | -0.0219 | 1.31 | 2.24 | 0.3301 | 0.3685 | 1.04 | 1,126,255.00 | -0.9143 | 3.17 | -1.28 | 4.68 | 94.19 | 93.00 | -2.77 | 7.44 | 1.67 | -0.5392 | 0.2915 | 9.82 | -9.38 | 45.40 | -33.94 | -- | 56.47 | -- |
| Tibet Weixinkang Pharmaceutical Co Ltd | 1.26bn | 247.04m | 4.37bn | 701.00 | 17.69 | 2.95 | -- | 3.48 | 0.5677 | 0.5677 | 2.89 | 3.41 | 0.6778 | 16.41 | 5.56 | 1,791,483.00 | 13.33 | 8.20 | 17.01 | 11.13 | 53.45 | 50.20 | 19.67 | 11.53 | 3.27 | -- | 0.0075 | 59.11 | -5.43 | 12.13 | 20.94 | 23.85 | -5.61 | 38.96 |
| Yabao Pharmaceutical Group Co Ltd | 2.83bn | 220.70m | 4.43bn | 4.14k | 20.12 | 1.50 | -- | 1.56 | 0.3057 | 0.3057 | 3.86 | 4.10 | 0.7389 | 3.51 | 6.66 | 683,686.80 | 5.11 | 2.82 | 6.38 | 3.97 | 52.85 | 59.20 | 6.92 | 4.19 | 2.04 | 129.51 | 0.0313 | 43.74 | 7.05 | -0.0572 | 90.71 | -6.10 | 7.98 | -9.71 |
| Shanghai New World Co Ltd | 1.13bn | 45.48m | 4.45bn | 1.20k | 97.87 | 1.05 | -- | 3.92 | 0.0703 | 0.0703 | 1.75 | 6.53 | 0.201 | 3.94 | 10.25 | 942,735.10 | 0.7905 | 0.5242 | 1.05 | 0.7249 | 38.77 | 33.70 | 3.93 | 2.71 | 1.57 | -- | 0.1158 | 82.75 | 33.39 | -16.40 | 160.85 | -35.00 | 53.61 | -25.42 |
Data as of Nov 06 2024. Currency figures normalised to Zhejiang Shouxiangu Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
9.79%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Orient Securities Asset Management Co. Ltd.as of 30 Jun 2024 | 4.86m | 2.47% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 3.99m | 2.02% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2024 | 3.09m | 1.57% |
| Huashang Fund Management Co., Ltd.as of 30 Jun 2024 | 2.25m | 1.14% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 1.26m | 0.64% |
| Bank of China Investment Management Co., Ltd.as of 30 Jun 2024 | 1.16m | 0.59% |
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2024 | 1.01m | 0.51% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 663.18k | 0.34% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 653.10k | 0.33% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 364.38k | 0.19% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
